In light of the global expansion of malaria into Central America, Florida, and Texas in 2023, the results of a landmark study confirm the benefits of combining the RTS,S/AS01E (RTS,S) (Mosquirix™) malaria vaccine with antimalarial drugs.
Read More
-
-
COVID-19 Pandemic Challenges Osteoporosis Management
-
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
-
Survival From COVID-19 High in Patients With Psoriasis
-
FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say
